ANIP — ANI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for ANI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	43	62.3	7.86	100	48.2
Net Total Accounts Receivable
Net Total Receivables	64.8	73.2	95.8	132	169
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	153	188	170	322	344
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38.1	40.6	41.3	52.7	43.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	431	457	461	772	760
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	166	61.7	78.6	87.5	99.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	233	244	265	413	422
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	197	213	196	359	339
Total Liabilities & Shareholders' Equity	431	457	461	772	760
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Discover the metrics influencing ANI Pharmaceuticals's share price